CoMIT pamphlet 2024
37/44

7F0711B8F0813BResponsible DepartmentDepartment of Cardiovascular Regenerative Medicine and Drug DiscoveryResearch PartnersSUZUKEN CO., LTD.Alpha MED Scientific Inc.AFI Corporation.Responsible DepartmentDepartment of NeurosurgeryResearch PartnerSysmex Corporation3636Focusing on drug discovery, the development of biological pacemakers, and the creation of organ-mimicking three-dimensional cardiac tissues, we will enhance each system and technology by leveraging cutting-edge innovations. Furthermore, we aim to devise sophisticated methods for acquiring and evaluating biomedical data essential for diagnosing and treating arrhythmias and heart failure, with the goal of integrating these advancements into societal applications.Based on highly sensitive and precision spectroscopic measurement technology, we aim to develop new diagnostic and testing technologies for maintaining people's health, providing gentler medical care and a drug discovery environment. Photonics measurement technology enables non-invasive and multiple informative measurement. For example, non-invasive analysis for iPS-derived cells and organoids is possible, and it is expected to support stable production and quality evaluation of them, and contributes to drug discovery and regenerative medicine. In addition, we can expect to contribute to medical care and health by evolving highly sensitive measurement at the molecular level and integration technology of analytical functions into microfluidic chips, and developing highly sensitive and low-cost nucleic acid testing device. In order to utilize these technologies as precise and easy diagnostic methods in the medical field, we will promote field-integrated research through an industry-government-academia collaboration system. School of Medicine and hospital in Osaka University will play a central role in collaborating with companies and Life and Medical Photonics Division in OTRI.A-31C-9LEE Jong-KookSpecially Appointed ProfessorDepartment of CardiovascularRegenerative Medicine and Drug DiscoveryKISHIMA HaruhikoProfessorDepartment of NeurosurgeryFUJITA KatsumasaProfessorGraduate School of EngineeringInnovation of cutting-edge fundamental technologies to accelerate drug discovery and regenerative medicine: Creation of physiologically-relevant cardiac tissues, and Development of system to acquire/evaluate biomedical information Research and development of precision diagnostics by highly sensitive spectroscopy(Life and Medical Photonics Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI))

元のページ  ../index.html#37

このブックを見る